Olatunji B. Alese, MD

One star
One star
One star
One star
One half star

Rating: 4.7 out of 5 (140 ratings)

Role

Medical Oncology
Specialty

Colorectal Cancer Bile Duct (Biliary) Cancer Esophageal Cancer Liver Cancer Neuroendocrine Tumors Pancreatic Cancer Stomach (Gastric) Cancer
Research Program

Discovery and Developmental Therapeutics
Practicing Since

2015

Request Appointment

Background

Olatunji B. Alese, MD, is Associate Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. Dr. Alese serves as director of gastrointestinal oncology at Winship Cancer Institute of Emory University. He joined the clinical staff at Winship Cancer Institute as a practicing physician in July 2015.

Dr. Alese is a member of the Discovery and Developmental Therapeutics research program at Winship Cancer Institute. He previously served on the Advisory Group of ASCO International Affairs Committee, and he is a member of several professional organizations.

Dr. Alese received his MD from University of Ibadan, Nigeria in 2000. His postgraduate medical education included residency training at University College Hospital in Nigeria and New York Medical College - Metropolitan Hospital Center. He completed his fellowship in Hematology/Oncology at Winship Cancer Institute of Emory University.

See Dr Alese's publications here.

Titles & Roles

Associate Professor, Department of Hematology and Medical Oncology

Emory University School of Medicine
Director of Gastrointestinal Oncology

Winship Cancer Institute of Emory University

Education & Training

Education

Fellowship, Hematology & Oncology, 2015
Emory University School of Medicine
Residency, Internal Medicine, 2012
New York Medical College (Metropolitan Hospital Center)
Residency, General Surgery, 2008
University College Hospital
Medical Education, , 2000
University Of Ibadan

Board Certifications

Hematology
American Board of Internal Medicine, 2016
Medical Oncology
American Board of Internal Medicine, 2016
Internal Medicine
American Board of Internal Medicine, 2012

View Current Clinical Trials


Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer Phase II Conditions Colon Adenocarcinoma, Microsatellite Stable Colon Carcinoma, Stage IIB Colon Cancer AJCC v8, Stage IIC Colon Cancer AJCC v8, Stage III Colon Cancer AJCC v8 Location Winship Cancer Institute
Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation Phase II/III Conditions Locally Advanced Rectal Carcinoma, Stage II Rectal Cancer AJCC v8, Stage III Rectal Cancer AJCC v8 Location Emory University Hospital Midtown, Emory Saint Joseph's Hospital, Winship Cancer Institute
A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers Phase I Conditions Colorectal Cancer, Gastric Cancer, Pancreatic Cancer, Ovarian Cancer Location Emory University Hospital Midtown, Winship Cancer Institute
A Study to Test Different Doses of BI 764532 in Patients With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3 Phase I Conditions Patients With Small Cell Lung Carcinoma and Other Neoplasms Location Winship Cancer Institute
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas Phase I Conditions Solid Tumors, Malignant Pleural Mesothelioma, Gastric Adenocarcinoma, Colorectal Adenocarcinoma, Sarcoma, Pancreatic Adenocarcinoma, Ewing Sarcoma, Chondrosarcoma, GIST, SDH-deficient Solid Tumors Location Winship Cancer Institute
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer Phase II Conditions Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Location Emory University Hospital Midtown, Emory Saint Joseph's Hospital, Emory Johns Creek Hospital, Winship Cancer Institute

Title/Journal	Authors	Publication Date
Survival trends for left and right sided colon cancer using population-based SEER database: A forty-five-year analysis from 1975 to 2019. Cancer medicine	MB Ulanja, KO Asafo-Agyei, V Neelam, BD Beutler, D Antwi-Amoabeng, SB Governor, GA Rahman, FT Djankpa, RN Ulanja, GB Nteim, T Mabrouk, M Amankwah, OB Alese	01/04/2024
Adjuvant Chemotherapy and Outcomes in Older Adult Patients With Biliary Tract Cancer. JAMA network open	OB Gbolahan, X Zhi, Y Liu, MM Shah, DA Kooby, OB Alese	02/01/2024
Isolated pulmonary metastases in pancreatic ductal adenocarcinoma: a review of current evidence. Cancer biology & therapy	OS Adekolujo, A Wahab, MO Akanbi, T Oyasiji, B Hrinczenko, OB Alese	31/12/2023
Shifting Sociodemographic Characteristics of a Phase I Clinical Trial Population at an NCI-Designated Comprehensive Cancer Center in the Southeast. The oncologist	CS Lalonde, JM Switchenko, M Behera, MA Bilen, TK Owonikoko, JL Kaufman, AK Nooka, CM Lewis, E Hitron, H Collins, EC Judson, OB Alese, R Donald Harvey, JW Carlisle	11/12/2023
Phase II trial of nivolumab and metformin in patients with treatment-refractory microsatellite stable metastatic colorectal cancer. Journal for immunotherapy of cancer	M Akce, B Farran, JM Switchenko, M Rupji, S Kang, L Khalil, A Ruggieri-Joyce, B Olson, WL Shaib, C Wu, OB Alese, M Diab, GB Lesinski, BF El-Rayes	01/10/2023
Nivolumab Plus Ipilimumab in Patients With Solid Tumors With ATM Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study. JCO precision oncology	N Rohatgi, M Rothe, PK Mangat, E Garrett-Mayer, F Meric-Bernstam, E Pisick, OB Alese, CM Reynolds, R Thota, GM Vaccaro, M von Mehren, RC Arend, VK Chiu, HL Duvivier, PJ Gold, K Hack, AS Marr, A Winer, GN Grantham, DC Hinshaw, A Gregory, S Halabi, RL Schilsky	01/09/2023
The impact of COVID-19 on mortality, length of stay, and cost of care among patients with gastrointestinal malignancies: A propensity score-matched analysis. Cancer medicine	MB Ulanja, BD Beutler, KO Asafo-Agyei, SB Governor, S Edusa, D Antwi-Amoabeng, RN Ulanja, GB Nteim, M Amankwah, V Neelam, GA Rahman, FT Djankpa, T Mabrouk, OB Alese	01/08/2023
Changes in Prescribing Patterns in Stage III Colon Cancer. Journal of the National Comprehensive Cancer Network : JNCCN	FS Ou, DJ Walden, JJ Larson, S Kang, CR Griswold, BE Ueberroth, B Patel, A Draper, P Raman, OB Alese, MB Sonbol, TS Bekaii-Saab, CS Wu, DH Ahn	01/08/2023
A Web-Based Dyadic Intervention to Manage Psychoneurological Symptoms for Patients With Colorectal Cancer and Their Caregivers: Protocol for a Mixed Methods Study. JMIR research protocols	Y Lin, LS Porter, W Chee, OB Alese, KA Curseen, MK Higgins, L Northouse, C Xiao	28/06/2023
Update on Emerging Therapies for Advanced Colorectal Cancer. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting	OB Alese, C Wu, WJ Chapin, MB Ulanja, B Zheng-Lin, M Amankwah, J Eads	01/05/2023
Factors Affecting Clinical Outcomes Among Patients Infected With HIV and Anal Cancer Treated With Modern Definitive Chemotherapy and Radiation Therapy. Advances in radiation oncology	NT Pfister, Y Cao, AJ Schlafstein, J Switchenko, PR Patel, MW McDonald, S Tian, JC Landry, OB Alese, C Gunthel, JY Lin	01/01/2023
Race, age, and sex differences on the influence of obesity on colorectal cancer sidedness and mortality: A national cross-sectional study. Journal of surgical oncology	MB Ulanja, C Ntafam, BD Beutler, D Antwi-Amoabeng, GA Rahman, RN Ulanja, T Mabrouk, SB Governor, FT Djankpa, OB Alese	01/01/2023
The Impact of Poorly Differentiated Histology on Immunotherapy in Advanced Gastrointestinal Cancers. Oncology	A Draper, EH Jung, Y Cao, RP Atallah, J Switchenko, S Kane, J Guadagno, AT Jones, E Brutcher, OB Alese	01/01/2023
Survival and Prognostic Factors in Patients With Pancreatic Colloid Carcinoma Compared With Pancreatic Ductal Adenocarcinoma. Pancreas	L Khalil, Z Huang, K Zakka, R Jiang, M Penley, OB Alese, WL Shaib, C Wu, M Behera, MD Reid, BF El-Rayes, M Akce	01/01/2023
ASO Author Reflections: Prognostic Factors in Gastrointestinal Extrapulmonary Small Cell Carcinoma Using Real-World Data. Annals of surgical oncology	MB Ulanja, BD Beutler, D Antwi-Amoabeng, SB Governor, GA Rahman, FT Djankpa, OB Alese	01/12/2022
ASO Visual Abstract: Prognostic Factors and Survival in Gastrointestinal Extrapulmonary Small Cell Carcinoma-A Retrospective Cohort Study. Annals of surgical oncology	MB Ulanja, BD Beutler, D Antwi-Amoabeng, SB Governor, GA Rahman, FT Djankpa, OB Alese	01/12/2022
Prognostic Factors and Survival in Gastrointestinal Extrapulmonary Small Cell Carcinoma: A Retrospective Cohort Study. Annals of surgical oncology	MB Ulanja, BD Beutler, D Antwi-Amoabeng, SB Governor, GA Rahman, FT Djankpa, OB Alese	01/12/2022
Biomarker analysis from a phase II multi-institutional study of nivolumab in patients with advanced refractory biliary tract cancer. European journal of cancer (Oxford, England : 1990)	DW Kim, YC Kim, BP Kovari, V Chung, OB Alese, BF El-Rayes, D Li, W Park, RD Kim	01/11/2022
Cobimetinib Plus Vemurafenib in Patients With Colorectal Cancer With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study. JCO precision oncology	KA Klute, M Rothe, E Garrett-Mayer, PK Mangat, R Nazemzadeh, KJ Yost, HL Duvivier, ER Ahn, TL Cannon, OB Alese, JC Krauss, R Thota, CJ Calfa, CS Denlinger, R O'Lone, S Halabi, GN Grantham, RL Schilsky	01/11/2022
Role of local therapy in the management of patients with metastatic anal squamous cell carcinoma: a National Cancer Database study. Journal of gastrointestinal oncology	RP Atallah, Y Zhang, K Zakka, R Jiang, Z Huang, WL Shaib, M Diab, M Akce, C Wu, BF El-Rayes, OB Alese	01/10/2022
Survival Outcomes of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer. The oncologist	L Khalil, X Gao, JM Switchenko, OB Alese, M Akce, C Wu, M Diab, BF El-Rayes, WL Shaib	02/09/2022
Cancer healthcare disparities among African Americans in the United States. Journal of the National Medical Association	E Mitchell, OB Alese, C Yates, BM Rivers, W Blackstock, L Newman, M Davis, G Byrd, AE Harris	01/06/2022
Circulating Tumor DNA: An Emerging Tool in Gastrointestinal Cancers. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting	OB Alese, N Cook, A Ortega-Franco, MB Ulanja, L Tan, J Tie	01/04/2022
Factors Affecting Inpatient Mortality and Length of Stay in Nonmetastatic Colorectal Cancer: Insights from the National Inpatient Sample. American journal of clinical oncology	MB Ulanja, BD Beutler, D Antwi-Amoabeng, AE Moody, PT Chang, GA Rahman, PA Apanga, OB Alese	01/01/2022
Comparing Somatostatin Analogs in the Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors. Oncology	MB Allaw, JM Switchenko, L Khalil, C Wu, OB Alese, M Akce, A Draper, AT Jones, B El-Rayes, W Shaib	01/01/2022
Early-onset pancreatic cancer: a review of molecular mechanisms, management, and survival. Oncotarget	MB Ulanja, AE Moody, BD Beutler, D Antwi-Amoabeng, GA Rahman, OB Alese	01/01/2022
Role of Resection of the Primary in Metastatic Well-Differentiated Neuroendocrine Tumors. Pancreas	WL Shaib, K Zakka, M Penley, R Jiang, M Akce, C Wu, SK Maithel, JM Sarmiento, D Kooby, M Behera, OB Alese, BF El-Rayes	01/11/2021
Correction: A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research	AM Monjazeb, A Giobbie-Hurder, A Lako, EM Thrash, RC Brennick, KZ Kao, C Manuszak, RD Gentzler, A Tesfaye, SK Jabbour, OB Alese, OE Rahma, JM Cleary, E Sharon, HJ Mamon, M Cho, H Streicher, HX Chen, MM Ahmed, A Mariño-Enríquez, S Kim-Schulze, S Gnjatic, E Maverakis, AI Marusina, AA Merleev, M Severgnini, KL Pfaff, J Lindsay, JL Weirather, S Ranasinghe, A Spektor, SJ Rodig, FS Hodi, JD Schoenfeld	01/09/2021
Safety and Efficacy of 7 Days on/7 Days off Versus 14 Days on/7 Days off Schedules of Capecitabine in Patients with Metastatic Colorectal Cancer: A Retrospective Review. Clinical colorectal cancer	E Bryson, E Sakach, U Patel, M Watson, K Hall, A Draper, C Davis, S Goyal, O Alese, M Akce, W Shaib, B El-Rayes, S Szabo, C Wu	01/06/2021
A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research	AM Monjazeb, A Giobbie-Hurder, A Lako, EM Thrash, RC Brennick, KZ Kao, C Manuszak, RD Gentzler, A Tesfaye, SK Jabbour, OB Alese, OE Rahma, JM Cleary, E Sharon, HJ Mamon, M Cho, H Streicher, HX Chen, MM Ahmed, A Mariño-Enríquez, S Kim-Schulze, S Gnjatic, E Maverakis, AI Marusina, AA Merleev, M Severgnini, KL Pfaff, J Lindsay, JL Weirather, S Ranasinghe, A Spektor, SJ Rodig, SF Hodi, JD Schoenfeld	01/05/2021
Survival Outcomes of Acinar Cell Pancreatic Cancer: A National Cancer Database Analysis. Pancreas	WL Shaib, K Zakka, W Huang, Z Chen, OB Alese, C Wu, M Akce, BF El-Rayes	01/04/2021
Is adjuvant chemotherapy beneficial for stage II-III goblet cell carcinoid/goblet cell adenocarcinoma of the appendix? Surgical oncology	K Zakka, S Williamson, R Jiang, MD Reid, OB Alese, WL Shaib, C Wu, M Behera, BF El-Rayes, M Akce	01/03/2021
Impact of Sarcopenia, BMI, and Inflammatory Biomarkers on Survival in Advanced Hepatocellular Carcinoma Treated With Anti-PD-1 Antibody. American journal of clinical oncology	M Akce, Y Liu, K Zakka, DJ Martini, A Draper, OB Alese, WL Shaib, C Wu, JP Wedd, MT Sellers, MA Bilen, BF El-Rayes	01/02/2021
Perioperative therapy in metastatic colorectal cancer: Pattern of use and survival outcomes. Journal of surgical oncology	OB Alese, K Zakka, X Huo, R Jiang, WL Shaib, M Akce, M Behera, P Sullivan, C Wu, BF El-Rayes	01/02/2021
Impact of high-risk features for stage II adenocarcinoma of the appendix. Cancer treatment and research communications	M Akce, K Zakka, M Penley, R Jiang, L Khalil, OB Alese, WL Shaib, C Wu, M Behera, BF El-Rayes	01/01/2021
Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma Treated With Liposomal Irinotecan. Frontiers in oncology	KH Yu, AE Hendifar, OB Alese, A Draper, M Abdelrahim, E Burns, G Khan, P Cockrum, RH Bhak, C Nguyen, M DerSarkissian, MS Duh, N Bahary	01/01/2021
High-Risk Features Are Prognostic in dMMR/MSI-H Stage II Colon Cancer. Frontiers in oncology	A Mohamed, R Jiang, PA Philip, M Diab, M Behera, C Wu, O Alese, WL Shaib, TM Gaines, GG Balch, BF El-Rayes, M Akce	01/01/2021
Impact of Tumor Side on Clinical Outcomes in Stage II and III Colon Cancer With Known Microsatellite Instability Status. Frontiers in oncology	M Akce, K Zakka, R Jiang, S Williamson, OB Alese, WL Shaib, C Wu, M Behera, BF El-Rayes	01/01/2021
Predictive and Prognostic Effects of Primary Tumor Size on Colorectal Cancer Survival. Frontiers in oncology	OB Alese, W Zhou, R Jiang, K Zakka, Z Huang, C Okoli, WL Shaib, M Akce, M Diab, C Wu, BF El-Rayes	01/01/2021
Phase I and Pharmacokinetic Study of Romidepsin in Patients with Cancer and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group Study. Clinical cancer research : an official journal of the American Association for Cancer Research	RM Connolly, E Laille, U Vaishampayan, V Chung, K Kelly, A Dowlati, OB Alese, RD Harvey, P Haluska, LL Siu, S Kummar, R Piekarz, SP Ivy, NM Anders, M Downs, A O'Connor, A Scardina, J Saunders, GL Rosner, MA Carducci, MA Rudek	15/10/2020
Phase 1 safety and pharmacodynamic study of lenalidomide combined with everolimus in patients with advanced solid malignancies with efficacy signal in adenoid cystic carcinoma. British journal of cancer	RD Harvey, BC Carthon, C Lewis, MS Hossain, C Zhang, Z Chen, WB Harris, OB Alese, W Shaib, MA Bilen, DH Lawson, C Wu, CE Steuer, BF El-Rayes, FR Khuri, S Lonial, EK Waller, SS Ramalingam, TK Owonikoko	01/10/2020
Survival outcome of adjuvant chemotherapy in deficient mismatch repair stage III colon cancer. Cancer	WL Shaib, KM Zakka, R Jiang, M Yan, OB Alese, M Akce, C Wu, M Behera, BF El-Rayes	15/09/2020
Radiation as a Single-Modality Treatment in Localized Pancreatic Cancer. Pancreas	WL Shaib, K Zakka, AA Shahin, F Yared, JM Switchenko, C Wu, M Akce, OB Alese, PR Patel, M Mcdonald, BF El-Rayes	01/07/2020
A Phase I Study of Safety, Pharmacokinetics, and Pharmacodynamics of Concurrent Everolimus and Buparlisib Treatment in Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research	TK Owonikoko, RD Harvey, B Carthon, Z Chen, C Lewis, H Collins, C Zhang, DH Lawson, OB Alese, MA Bilen, GL Sica, CE Steuer, WL Shaib, C Wu, WB Harris, M Akce, RR Kudchagkar, BF El-Rayes, S Lonial, SS Ramalingam, FR Khuri	01/06/2020
A Phase 2 Multi-institutional Study of Nivolumab for Patients With Advanced Refractory Biliary Tract Cancer. JAMA oncology	RD Kim, V Chung, OB Alese, BF El-Rayes, D Li, TE Al-Toubah, MJ Schell, JM Zhou, A Mahipal, BH Kim, DW Kim	01/06/2020
Blood-based next-generation sequencing analysis of neuroendocrine neoplasms. Oncotarget	K Zakka, R Nagy, L Drusbosky, M Akce, C Wu, OB Alese, BF El-Rayes, PM Kasi, K Mody, J Starr, WL Shaib	12/05/2020
In-hospital 30-day mortality for older patients with pancreatic cancer undergoing pancreaticoduodenectomy. Journal of geriatric oncology	WL Shaib, K Zakka, FN Hoodbhoy, A Belalcazar, S Kim, K Cardona, MC Russell, SK Maithel, JM Sarmiento, C Wu, M Akce, OB Alese, BF El-Rayes	01/05/2020
Blood-Based Next-Generation Sequencing Analysis of Appendiceal Cancers. The oncologist	WL Shaib, K Zakka, C Staley, A Roberts, M Akce, C Wu, OB Alese, BF El-Rayes	01/05/2020
High-Grade Gastrointestinal Neuroendocrine Carcinoma Management and Outcomes: A National Cancer Database Study. The oncologist	OB Alese, R Jiang, W Shaib, C Wu, M Akce, M Behera, BF El-Rayes	01/05/2020
Young Adults With Pancreatic Cancer: National Trends in Treatment and Outcomes. Pancreas	OB Alese, R Jiang, W Shaib, C Wu, M Akce, T Gaines, L Ni, M Behera, BF El-Rayes	01/03/2020
Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy. The oncologist	MA Bilen, DJ Martini, Y Liu, JM Shabto, JT Brown, M Williams, AI Khan, A Speak, C Lewis, H Collins, HT Kissick, BC Carthon, M Akce, WL Shaib, OB Alese, RN Pillai, CE Steuer, CS Wu, DH Lawson, RR Kudchadkar, BF El-Rayes, SS Ramalingam, TK Owonikoko, RD Harvey, VA Master	01/03/2020
Adiposity may predict survival in patients with advanced stage cancer treated with immunotherapy in phase 1 clinical trials. Cancer	DJ Martini, MR Kline, Y Liu, JM Shabto, MA Williams, AI Khan, C Lewis, H Collins, M Akce, HT Kissick, BC Carthon, WL Shaib, OB Alese, RN Pillai, CE Steuer, CS Wu, DH Lawson, RR Kudchadkar, BF El-Rayes, SS Ramalingam, TK Owonikoko, RD Harvey, VA Master, MA Bilen	01/02/2020
Clinicopathological features and survival outcomes of rare histologic variants of gallbladder cancer. Journal of surgical oncology	M Akce, K Zakka, M Penley, R Jiang, OB Alese, WL Shaib, C Wu, M Behera, BF El-Rayes	01/02/2020
Correlation Patterns Among B7 Family Ligands and Tryptophan Degrading Enzymes in Hepatocellular Carcinoma. Frontiers in oncology	R Chinnadurai, R Scandolara, OB Alese, D Arafat, D Ravindranathan, AB Farris, BF El-Rayes, G Gibson	01/01/2020
Analysis of racial disparities in the treatment and outcomes of colorectal cancer in young adults. Cancer epidemiology	OB Alese, R Jiang, KM Zakka, C Wu, W Shaib, M Akce, M Behera, BF El-Rayes	01/12/2019
Clinical Outcomes of Small Bowel Adenocarcinoma. Clinical colorectal cancer	M Akce, R Jiang, K Zakka, C Wu, OB Alese, WL Shaib, M Behera, BF El-Rayes	01/12/2019
Clinical outcomes of advanced stage cancer patients treated with sequential immunotherapy in phase 1 clinical trials. Investigational new drugs	DJ Martini, Y Liu, JM Shabto, C Lewis, MR Kline, H Collins, M Akce, HT Kissick, BC Carthon, WL Shaib, OB Alese, RN Pillai, CE Steuer, CS Wu, DH Lawson, RR Kudchadkar, VA Master, BF El-Rayes, SS Ramalingam, TK Owonikoko, RD Harvey, MA Bilen	01/12/2019
Optimizing cancer care for hepatocellular carcinoma at a safety-net hospital: The value of a multidisciplinary disease management team. Journal of surgical oncology	G Duininck, AG Lopez-Aguiar, RM Lee, L Miller, S Dariushnia, C Wu, OB Alese, JY Lin, J Wedd, A Adams, SK Maithel, MC Russell	01/12/2019
Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms. British journal of cancer	IH Sahin, M Akce, O Alese, W Shaib, GB Lesinski, B El-Rayes, C Wu	01/11/2019
Rosai-Dorfman Disease of the Pancreas Shows Significant Histologic Overlap With IgG4-related Disease. The American journal of surgical pathology	J Tracht, MD Reid, Y Xue, E Madrigal, JM Sarmiento, D Kooby, OB Alese, AM Krasinskas	01/11/2019
Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy. BMC cancer	MA Bilen, JM Shabto, DJ Martini, Y Liu, C Lewis, H Collins, M Akce, H Kissick, BC Carthon, WL Shaib, OB Alese, CE Steuer, C Wu, DH Lawson, R Kudchadkar, VA Master, B El-Rayes, SS Ramalingam, TK Owonikoko, RD Harvey	29/08/2019
Induction Therapy in Localized Pancreatic Cancer. Pancreas	WL Shaib, L Sayegh, C Zhang, A Belalcazar, A Ip, OB Alese, M Akce, C Wu, Y Qu, SK Maithel, D Kooby, K Cardona, JM Sarmeinto, BF El-Rayes	01/08/2019
High-Grade Gastrointestinal Neuroendocrine Carcinoma Management and Outcomes: A National Cancer Database Study. The oncologist	OB Alese, R Jiang, W Shaib, C Wu, M Akce, M Behera, BF El-Rayes	01/07/2019
US Cancer Centers of Excellence Strategies for Increased Inclusion of Racial and Ethnic Minorities in Clinical Trials. Journal of oncology practice	JM Regnante, NA Richie, L Fashoyin-Aje, M Vichnin, M Ford, UB Roy, K Turner, LL Hall, E Gonzalez, N Esnaola, LT Clark, HC Adams, OB Alese, K Gogineni, L McNeill, D Petereit, I Sargeant, J Dang, C Obasaju, Q Highsmith, SC Lee, SC Hoover, EL Williams, MS Chen	01/04/2019
Gastric squamous cell carcinoma and gastric adenosquamous carcinoma, clinical features and outcomes of rare clinical entities: a National Cancer Database (NCDB) analysis. Journal of gastrointestinal oncology	M Akce, R Jiang, OB Alese, WL Shaib, C Wu, M Behera, BF El-Rayes	01/02/2019
Role of adjuvant therapy in resected stage IA subcentimeter (T1a/T1b) pancreatic cancer. Cancer	WL Shaib, AS Narayan, JM Switchenko, SR Kane, C Wu, M Akce, OB Alese, PR Patel, SK Maithel, JM Sarmiento, DA Kooby, BF El-Rayes	01/01/2019
The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced-stage cancer treated with immunotherapy. Cancer	MA Bilen, DJ Martini, Y Liu, C Lewis, HH Collins, JM Shabto, M Akce, HT Kissick, BC Carthon, WL Shaib, OB Alese, RN Pillai, CE Steuer, CS Wu, DH Lawson, RR Kudchadkar, BF El-Rayes, VA Master, SS Ramalingam, TK Owonikoko, RD Harvey	01/01/2019
Clinical outcomes of rare hepatocellular carcinoma variants compared to pure hepatocellular carcinoma. Journal of hepatocellular carcinoma	K Zakka, R Jiang, OB Alese, WL Shaib, C Wu, JP Wedd, MT Sellers, M Behera, BF El-Rayes, M Akce	01/01/2019
Analysis of Opioid Use Following Curative Cancer Treatment at a Large Urban Safety-net Hospital. The Clinical journal of pain	AS Cass, JT Alese, C Kim, MA Curry, JA LaFollette, Z Chen, OB Alese	01/10/2018
Evaluation of Treatment Patterns and Survival Outcomes in Elderly Pancreatic Cancer Patients: A Surveillance, Epidemiology, and End Results-Medicare Analysis. The oncologist	WL Shaib, JS Jones, M Goodman, JM Sarmiento, SK Maithel, K Cardona, S Kane, C Wu, OB Alese, BF El-Rayes	01/06/2018
Phase 1b study of pasireotide, everolimus, and selective internal radioembolization therapy for unresectable neuroendocrine tumors with hepatic metastases. Cancer	HS Kim, WL Shaib, C Zhang, GP Nagaraju, C Wu, OB Alese, Z Chen, E Brutcher, M Renfroe, BF El-Rayes	01/05/2018
Race-, Age-, and Gender-Based Characteristics and Toxicities of Targeted Therapies on Phase I Trials. Oncology	TK Owonikoko, AK Busari, S Kim, Z Chen, A Akintayo, C Lewis, BC Carthon, OB Alese, BF El-Rayes, SS Ramalingam, RD Harvey	01/01/2018
Appendiceal Mucinous Neoplasms: Diagnosis and Management. The oncologist	WL Shaib, R Assi, A Shamseddine, OB Alese, C Staley, B Memis, V Adsay, T Bekaii-Saab, BF El-Rayes	01/01/2018
Appendiceal Mucinous Neoplasms: Diagnosis and Management. The oncologist	WL Shaib, R Assi, A Shamseddine, OB Alese, C Staley, B Memis, V Adsay, T Bekaii-Saab, BF El-Rayes	01/09/2017
Rosai-Dorfman Disease Manifesting as a Pancreatic Head Mass Diagnosed Nonoperatively. Journal of oncology practice	DJ Smith, A Sekhar, B Memis, VN Adsay, OB Alese	01/01/2017
Novel synthetic curcumin analogs as potent antiangiogenic agents in colorectal cancer. Molecular carcinogenesis	B Rajitha, GP Nagaraju, WL Shaib, OB Alese, JP Snyder, M Shoji, S Pattnaik, A Alam, BF El-Rayes	01/01/2017
Aquaporins: Their role in gastrointestinal malignancies. Cancer letters	GP Nagaraju, R Basha, B Rajitha, OB Alese, A Alam, S Pattnaik, B El-Rayes	01/04/2016
Contemporary Management of Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer. The oncologist	WL Shaib, A Ip, K Cardona, OB Alese, SK Maithel, D Kooby, J Landry, BF El-Rayes	01/02/2016
Therapy-related acute myeloid leukemia following radioactive iodine treatment for thyroid cancer. Cancer causes & control : CCC	A Oluwasanjo, R Pathak, A Ukaigwe, O Alese	01/01/2016
MicroRNAs as biomarkers and prospective therapeutic targets in colon and pancreatic cancers. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine	GP Nagaraju, AS Madanraj, S Aliya, B Rajitha, OB Alese, E Kariali, A Alam, BF El-Rayes	01/01/2016
Analysis of liver-directed therapies in U.S. cancer patients. Current oncology (Toronto, Ont.)	OB Alese, S Kim, Z Chen, SS Ramalingam, TK Owonikoko, BF El-Rayes	01/12/2015
Management patterns and predictors of mortality among US patients with cancer hospitalized for malignant bowel obstruction. Cancer	OB Alese, S Kim, Z Chen, TK Owonikoko, BF El-Rayes	01/06/2015
Management and Outcomes of Hospitalized Patients With Primary Neuroendocrine Tumor and Non-Neuroendocrine Tumor Appendiceal Cancers in the United States. World journal of oncology	OB Alese, S Kim, Z Chen, W Shaib, CA Staley, SS Ramalingam, TK Owonikoko, BF El-Rayes	01/06/2015

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.

4.8	One star One star One star One star One half star	Provider showed concern
4.8	One star One star One star One star One half star	Provider explained things clearly
4.7	One star One star One star One star One half star	Provider discussed treatment options
4.7	One star One star One star One star One half star	Provider included you in decisions
4.7	One star One star One star One star One half star	Likelihood of recommending this provider

View Reviews


One star One star One star One star One star	05/04/2024	Everyone was prompt and professional.
One star One star One star One star One star	23/02/2024	Very Good
One star One star One star One star One star	24/09/2023	I was very satisfied with my care provider.
One star One star One star One star One star	15/09/2023	Doctor explained how a notable but stable scan observation wan not currently problematic and would be closely monitored. He reviewed and discussed with me short-term surveillance plans.
One star One star One star One star One star	23/08/2023	Even though he was running late,Dr Alese was patient and took the time to explain and listen. He did not seem rushed or hurried
One star One star One star One star One half star	12/08/2023	Dr Alese was excellent he was very concerned and described my cancer so that I could understand what kind I actually had and the treatments that it require. He also went over differant treatments. I like him a lot and he made me feel so much better
One star One star One star One star One star	11/08/2023	Dr. Aleshe was very good
One star One star One star One star One star	09/06/2023	Good
One star One star One star One star One star	12/05/2023	Amazing nursing staff & physician!
One star One star One star One star One star	17/03/2023	The doctor went over and above to address concerns about my condition and concerns. Dr. Alese provided me with a great doctor/patient experience.
One star One star One star One star One star	30/01/2023	Dr. Alese and staff are the greatest! I can not ask for better care than what I have received from everyone
One star One star One star One star One star	27/01/2023	All the members of the team took time to sit down, look directly at me and talk in language I could understand. I appreciated their unhurried and caring manner
One star One star One star One star One star	09/01/2023	I was very impressed with Dr. Alese. He was very approachable & knowledgeable. He expressed concern about my case & provided me with good information & options for my care. I truly appreciate him.
One star One star One star One star One star	08/01/2023	1st visit and can absolutely say his care , concern and attention to my condition was greatly appreciated. I look forward to being and his and his medical team patient.
One star One star One star One star One star	06/01/2023	I am so very thankful for Dr Alese. I can't imagine navigating treatment without him. He is kind, always patient, supportive and helpful.
One star One star One star One star One star	06/12/2022	The team is awesome. Dr.Alese was excellent as usual. He really shows that he cares about your health. I love how he takes the time to answer all of our questions and doesn't mind that I call my kids and they listen in and he always ask do they have any questions. I feel really Bless to have Dr. Alese and his team as my doctors.
One star One star One star One star Empty star	19/07/2022	The doctor, when physically present, is excellent. It is very difficult however to get input and advice when calling his office
One star One star One star One star One star	26/06/2022	This could not have been any better. Dr. Alese showed great concern no rush and made sure all of our questions were answered.